SEB Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
SEB Asset Management's DGX Position: Q3 2026 in Review
SEB Asset Management reduced its Quest Diagnostics (DGX) stake by 2.4% in Q3 2026, selling an estimated $994K and leaving 178,606 shares worth $41.6M. The position accounts for 0.15% of the portfolio, ranked #124.
SEB Asset Management first reported a position in DGX in Q1 2026 and has held it in 3 quarters since. 1,137 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- SEB Asset Management held 178,606 shares of Quest Diagnostics worth $41.6M as of Q3 2026.
- SEB Asset Management sold 4,300 Quest Diagnostics shares in Q3 2026, an estimated $994K.
- Quest Diagnostics made up 0.15% of SEB Asset Management's portfolio in Q3 2026, its #124 holding.
- SEB Asset Management first reported a position in Quest Diagnostics in Q1 2026 and has held it in 3 quarters since.
- 1,137 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.